iCapital - Blackstone Life Sciences VI Access Fund L.P. — Form D/A
iCapital - Blackstone Life Sciences VI Access Fund L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-09-08. $116.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-09-08
- Form: D/A
- Accession: 0002033548-25-000117
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $116.9M
- Investors: 297
- Date of first sale: 2024-12-09
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-523561
Issuer
- Name: iCapital - Blackstone Life Sciences VI Access Fund L.P.
- CIK: 0002023982
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: C/O COMPLIANCE DEPARTMENT, NEW YORK, NY, 10165
- Phone: (212) 994-7400
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Mallory Ross | Executive Officer | New York, NY |
| -- iCapital PE GP, LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More